Chlamydia Complications: PID, Infertility, Epididymitis & More

How Chlamydia Causes Damage Without Symptoms

Chlamydia trachomatis is uniquely effective at causing long-term reproductive damage precisely because it provokes so little immediate immune response. The bacterium replicates inside epithelial cells, shielded from the immune system. This allows it to persist for months or years — silently inducing a low-grade, chronic inflammatory state that gradually damages the tissues it infects.

The damage mechanism is primarily immunopathological: it is the host’s own immune response, sustained over time against a persistent intracellular pathogen, that causes tissue injury. Heat shock proteins expressed by chlamydia — particularly chlamydial HSP60 — may trigger cross-reactive autoimmune responses against host reproductive tissue, contributing to fibrosis and scarring even in the absence of symptomatic infection.

This is the central reason why a negative symptom history provides no reassurance about chlamydia status, and why routine testing for sexually active young people is so clinically important.

Pelvic Inflammatory Disease (PID)

PID is the most significant complication of chlamydia in women. It occurs when infection ascends from the cervix through the uterus and into the fallopian tubes and ovaries, causing inflammation of the upper genital tract. Chlamydia is the most commonly identified cause of PID in the UK, though other organisms (particularly Mycoplasma genitalium and anaerobes) frequently co-exist.

Symptoms of PID

• Pelvic or lower abdominal pain — bilateral, dull, or aching
• Fever (temperature above 38√C) — in more severe cases
• Abnormal vaginal discharge
• Pain during sex (deep dyspareunia)
• Irregular vaginal bleeding — intermenstrual or post-coital
• Cervical motion tenderness on internal examination

Treatment of PID

PID treatment requires broader antibiotic coverage than simple chlamydia treatment, because multiple organisms are typically involved. BASHH guidelines recommend combination therapy covering chlamydia, gonorrhoea, and anaerobic organisms. Typical outpatient regimens include intramuscular ceftriaxone plus oral doxycycline plus oral metronidazole for 14 days. Severe PID requires inpatient intravenous antibiotics. All sexual partners should be tested and treated.

Tubal Factor Infertility

Repeated or inadequately treated episodes of PID cause progressive scarring and fibrosis of the fallopian tubes. The consequences range from partial obstruction — reducing tubal function and fertility — to complete bilateral tubal occlusion, producing absolute tubal factor infertility. This cannot be reversed without surgical intervention (tubal surgery or IVF).

Crucially, tubal damage can occur following subclinical (silent) PID — inflammation of the fallopian tubes that produces no noticeable symptoms in the woman. A significant proportion of women with tubal factor infertility have no history of symptomatic PID but have serological evidence of past chlamydial infection. The implication is that silent chlamydia — which most infected women have — can cause irreversible tubal damage over months or years of undetected infection.

Ectopic Pregnancy

Scarring and partial obstruction of the fallopian tubes from PID or subclinical salpingitis increases the risk of ectopic pregnancy — a pregnancy that implants outside the uterine cavity, most commonly in a fallopian tube. When a fertilised egg cannot pass freely through a damaged tube to reach the uterus, it may implant in the tube itself. The tube cannot expand to accommodate the growing embryo, and tubal rupture — a life-threatening obstetric emergency — occurs if the ectopic is not identified and treated early.

Chlamydia seropositivity is one of the strongest risk factors for ectopic pregnancy. Studies have identified a 6–9-fold increased risk of ectopic pregnancy in women with prior chlamydial infection compared with uninfected women. This risk persists even after successful antibiotic treatment — once tubal scarring is established, it does not resolve with antibiotic therapy.

Epididymo-Orchitis in Men

In men, untreated urethral chlamydia can spread posteriorly to infect the epididymis — the coiled tubular structure attached to the back of each testis through which sperm mature and travel. Infection of the epididymis (epididymitis) may spread to involve the testis itself (orchitis) — together termed epididymo-orchitis.

Symptoms

• Unilateral testicular pain — may develop gradually or acutely
• Testicular or scrotal swelling
• Tenderness of the epididymis on palpation
• Fever and general malaise in more severe cases
• May be accompanied by urethral discharge or dysuria

Fertility impact in men

Untreated or recurrent epididymitis can cause fibrosis and obstruction of the epididymal tubules, impairing sperm transport (obstructive azoospermia or oligozoospermia). Bilateral epididymitis carries the highest fertility risk. Anti-sperm antibodies may also be generated in response to orchitis, further impairing fertility. Prompt treatment of urethral chlamydia is the most effective preventive strategy.

Treatment of epididymo-orchitis

Epididymo-orchitis in men under 35 is predominantly caused by sexually transmitted organisms (chlamydia, gonorrhoea). BASHH recommends treating as for chlamydia and gonorrhoea empirically while awaiting culture results. Doxycycline 100 mg twice daily for 10–14 days (rather than the standard 7-day course) is recommended for epididymo-orchitis. Scrotal support and NSAIDs for pain relief are also recommended. Attend a sexual health clinic or GP promptly — do not self-treat with over-the-counter analgesics alone.

Reactive Arthritis

Reactive arthritis (formerly Reiter’s syndrome) is an inflammatory arthritis triggered by infection at a distant site — in this case, the genitourinary tract. It typically develops 2–6 weeks after chlamydial infection and is characterised by the classic triad of arthritis, urethritis, and conjunctivitis, though not all three elements are present in every case.

• Arthritis — typically asymmetric, oligoarticular (affecting a few large joints), predominantly affecting the knees, ankles, and feet
• Urethritis — may persist or recur after the initial chlamydial infection has been treated
• Conjunctivitis or uveitis — eye inflammation; uveitis requires urgent ophthalmological assessment to prevent vision impairment
• Enthesitis — inflammation at tendon insertion sites, particularly the heel (Achilles tendon enthesitis or plantar fasciitis)
• Skin and mucosal lesions — keratoderma blenorrhagica (pustular skin lesions on soles and palms) and circinate balanitis (painless lesions on the glans penis) in some cases

Reactive arthritis is more common in men than women, and occurs significantly more often in individuals carrying the HLA-B27 antigen (approximately 60–80% of affected individuals are HLA-B27 positive). Most episodes resolve within 3–6 months, but a minority develop chronic or recurrent disease. Management involves NSAIDs for symptomatic relief, physical therapy, and in severe or refractory cases, disease-modifying antirheumatic drugs (DMARDs) under rheumatological supervision.

Fitz-Hugh-Curtis Syndrome

Fitz-Hugh-Curtis syndrome (perihepatitis) is a rare but clinically important complication, almost exclusively seen in women, in which inflammation spreads from the pelvic organs to the liver capsule. It is characterised by right upper quadrant (RUQ) pain that may be severe and pleuritic in nature — worsening on inspiration — and is easily confused with biliary or hepatic pathology. It occurs in approximately 5–10% of women with PID and is caused by the same organisms — chlamydia in particular. Liver function tests are typically normal or only mildly elevated. Treatment is the same as for PID.

Preventing Complications: What You Can Do

Every complication described on this page is preventable. The pathway from chlamydia to infertility, ectopic pregnancy, or reactive arthritis runs entirely through the avoidable step of untreated or late-diagnosed infection. Prevention involves three interconnected actions.

• Test regularly. Annual testing for sexually active people under 25, and after any new partner, is the single most effective intervention. Complications are a consequence of prolonged untreated infection, not of the infection itself — and prolonged infection is almost always a consequence of late or absent testing.
• Treat promptly. A confirmed positive result should be followed by antibiotic treatment within days, not weeks. Every day of delay is a day of ongoing inflammation. See our doxycycline guide and azithromycin guide.
• Notify partners. Reinfection from an untreated partner resets the clock on inflammation. All recent partners must be informed, tested, and treated to break the cycle.